Skip to main content
EXCELSIOR logo

EXCELSIOR — Investor Relations & Filings

Ticker · 4104 ISIN · TW0004104005 TW Human health and social work activities
Filings indexed 1,662 across all filing types
Latest filing 2024-04-24 Major Shareholding Noti…
Country TW Taiwan
Listing TW 4104

About EXCELSIOR

www.excelsiormedical.com.tw

Excelsior Medical Co., Ltd. is a comprehensive medical service provider specializing in the distribution and integration of medical equipment and healthcare solutions. Originally established as a distributor of hemodialysis consumables, the company has evolved into a diversified healthcare group. Its core business activities encompass the supply of specialized medical products, including hemodialysis and plasma exchange systems, blood bags, artificial stoma products, and scar care solutions. Beyond clinical equipment, the company provides hospital management services and operates in sectors such as respiratory therapy, ophthalmology, rehabilitation, and long-term care. Excelsior Medical also distributes premium health appliances and medical aesthetic products, catering to both professional medical institutions and consumer markets. By integrating innovative technologies with systematic management, the company delivers customized healthcare solutions.

Recent filings

Filing Released Lang Actions
113年04月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes before and after a shareholders' meeting date. It includes specific shareholding numbers and dates but does not contain financial statements, management discussion, or report narratives. The document length is short (1059 characters) and it is a factual shareholding notification related to shareholder meeting changes. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2024-04-24 Chinese
113年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing data on loan balances and guarantee endorsements for the current and previous months. It contains no detailed financial statements, management discussion, or comprehensive report content. The length is very short (630 characters), and it appears to be a regulatory disclosure of financial guarantees and related party transactions. There is no indication of it being an annual or interim report, earnings release, or other detailed report. It fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-04-10 Chinese
113年3月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 佳醫, presented in a tabular format with explanations about accounting standards and reporting practices. It contains financial data for a specific month (March 2024) and compares it to the previous year. The document length is short (772 characters) and it does not appear to be a full financial report but rather a brief financial summary or factsheet. There is no indication that this is an announcement of a report publication, nor is it a detailed annual or interim report. Given the concise nature and focus on key financial figures, this fits best as a Fund Information / Factsheet (FS) type document.
2024-04-10 Chinese
113年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document is a detailed disclosure of shareholdings by insiders, including directors, chairpersons, and other key personnel, showing their stock ownership changes and holdings. It is a typical insider shareholding notification or director's dealing report. There is no indication of financial statements, earnings, management discussion, or other report types. The document is not an announcement of a report but a direct disclosure of insider shareholdings. Therefore, it fits best under Director's Dealing (DIRS).
2024-04-03 Chinese
113年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledges of shares by company insiders, including directors, supervisors, and major shareholders. It includes specific data on share counts held at appointment and currently held, as well as pledges and related percentages. The document is titled with the company name and appears to be a disclosure of insider shareholdings and related information. There is no indication of financial statements, earnings data, or management discussion. The content aligns with reporting of insider shareholdings or director dealings rather than a full report or announcement. Given the nature of the data—personal share transactions and holdings by directors and executives—this document fits best under the category of Director's Dealing (DIRS). The document length is relatively short and focused solely on insider shareholdings, supporting this classification.
2024-04-03 Chinese
113年03月法人說明會簡報 — 410420240327E002.pdf
Investor Presentation Classification · 95% confidence The document is titled 'Excelsior Medical Co., Ltd. Investor Conference 2024/3/27' and contains detailed financial data including revenue structure, operating overview, profit after tax, balance sheet items (assets, liabilities, equity), statement of comprehensive income, cash flow statements (operating, investing, financing activities), and business overview. The financial figures are based on audited or reviewed financial statements and are presented according to IFRS. The document is a presentation format with detailed financials and business strategy information aimed at investors. It is not a full annual report filing (10-K) but rather a detailed investor presentation with comprehensive financial data and business overview. The length is 9087 characters, which is substantial and contains substantive financial data and analysis. Therefore, the document best fits the category of Investor Presentation (IP).
2024-03-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.